Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab
Author:
Affiliation:
1. Department of Dermatology and Venereology the First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang 325000 China
Publisher
Oxford University Press (OUP)
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21776
Reference8 articles.
1. JAK inhibitors in the treatment of atopic dermatitis;Chovatiya;J Allergy Clin Immunol,2021
2. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2;Cork;J Dermatolog Treat,2020
3. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis;Halling;J Am Acad Dermatol,2021
4. Management of inadequate response and adverse effects to dupilumab in atopic dermatitis;Narla;J Am Acad Dermatol,2022
5. Innovation in atopic dermatitis: from pathogenesis to treatment;Munera-Campos;Actas Dermosifiliogr (Engl Ed),2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab;World Allergy Organization Journal;2024-07
2. Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis;Journal of the European Academy of Dermatology and Venereology;2024-05-29
3. Update of systemic treatments in severe/recalcitrant atopic dermatitis: Consensus document of the KAAACI working group on atopic dermatitis;Allergy, Asthma & Respiratory Disease;2024
4. Interactions between Malassezia and New Therapeutic Agents in Atopic Dermatitis Affecting Skin Barrier and Inflammation in Recombinant Human Epidermis Model;International Journal of Molecular Sciences;2023-03-24
5. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges;Archives of Pharmacal Research;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3